A new lawsuit has been filed by a plaintiff from Madison, Indiana, who claims that the makers of Suboxone failed to warn users about the drug’s severe dental damage risks. The lawsuit alleges that Indivior and Aquestive Therapeutics knew about these risks for over a decade but didn’t provide proper warnings. Despite a 2022 FDA alert confirming the dental issues linked to buprenorphine products dissolved in the mouth, the plaintiff argues that the medication guides were never updated adequately.
[fluentform id=”15″]
